Maik Luu

Lehrstuhl für Zelluläre Immuntherapie, Universitätsklinikum Würzburg

Affiliated withUniversitätsklinikum Würzburg Fraunhofer Institut für Zelltherapie und Immunologie (IZI)Universitätsklinikum Würzburg

Research Area

Biography

Maik Luu has not added Biography.
If you are Maik Luu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title	2026
Publication title	2026

Other Publications

Article	Year
Microbial short-chain fatty acids modulate CD8 T cell responses and improve adoptive immunotherapy for cancer. Nature communications\| PubMed ID: 34210970	2021
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia. Blood\| PubMed ID: 34289026	2021
The Role of Short-Chain Fatty Acids and Bile Acids in Intestinal and Liver Function, Inflammation, and Carcinogenesis. Frontiers in cell and developmental biology\| PubMed ID: 34381785	2021
Microbial metabolites: novel therapeutic tools for boosting cancer therapies. Trends in cell biology\| PubMed ID: 34538658	2021
Transcription factor c-Rel mediates communication between commensal bacteria and mucosal lymphocytes. Journal of leukocyte biology\| PubMed ID: 34622991	2022
Time to evolve: predicting engineered T cell-associated toxicity with next-generation models. Journal for immunotherapy of cancer\| PubMed ID: 35577500	2022
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside? Journal for immunotherapy of cancer\| PubMed ID: 35577501	2022
Verteporfin protects against Th17 cell-mediated EAE independently of YAP inhibition. European journal of immunology\| PubMed ID: 35776890	2022
Selected commensals educate the intestinal vascular and immune system for immunocompetence. Microbiome\| PubMed ID: 36171625	2022
Targeting metabolic rewiring might decrease spread of tumor cells: Mitochondrial tRNA modifications promote cancer metastasis. Signal transduction and targeted therapy\| PubMed ID: 36209139	2022
Lactate induces metabolic and epigenetic reprogramming of pro-inflammatory Th17 cells. EMBO reports\| PubMed ID: 36215678	2022
The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment. Cancers\| PubMed ID: 36900377	2023
Learning from the microbes: exploiting the microbiome to enforce T cell immunotherapy. Frontiers in immunology\| PubMed ID: 37799719	2023
Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple product versions and T2EVOLVE recommendations. Frontiers in immunology\| PubMed ID: 38077331	2023
Lymphodepletion - an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle. Frontiers in immunology\| PubMed ID: 38187393	2023
Sodium chloride in the tumor microenvironment enhances T cell metabolic fitness and cytotoxicity. Nature immunology\| PubMed ID: 39198632	2024
Dissecting the metabolic signaling pathways by which microbial molecules drive the differentiation of regulatory B cells. Mucosal immunology\| PubMed ID: 39265892	2025
Metabolization of microbial postbiotic pentanoate drives anti-cancer CAR T cells. bioRxiv : the preprint server for biology\| PubMed ID: 39314273	2025
-derived metabolites protect mice against colonic inflammation. Gut microbes\| PubMed ID: 39397690	2024
Optimizing CAR-T treatment: A TEVOLVE guide to raw and starting material selection. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 39533710	2025
Modulation of Host Immunity by Microbiome-Derived Indole-3-Propionic Acid and Other Bacterial Metabolites. European journal of immunology\| PubMed ID: 40170399	2025
European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoring. Frontiers in immunology\| PubMed ID: 40342422	2025
Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe. Blood advances\| PubMed ID: 40991391	2025
Fine tuning towards the next generation of engineered T cells. Nature biomedical engineering\| PubMed ID: 41073806	2025
Breaking T-cell tolerance to fight multiple myeloma. Blood\| PubMed ID: 41196620	2025
Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe. Cytotherapy\| PubMed ID: 41217312	2025